The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)

NCT05971732 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction
Iron Deficiency
Acute Heart Failure

Interventions

DRUG: Ferric derisomaltose
DRUG: Placebo

Sponsor

China-Japan Friendship Hospital